NASDAQ : IMUX
Immunic, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 7.51 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 102.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 27.24M | 21.25M | 18.01M | 16.01M | 15.26M | 13.30M |
| Research & Development | 90.64M | 81.98M | 80.05M | 83.22M | 71.25M | 61.12M |
| Operating Expenses | 117.88M | 103.23M | 98.05M | 99.22M | 86.52M | 74.42M |
| Operating Income | -117.88M | -103.23M | -98.05M | -99.22M | -86.52M | -74.42M |
| Interest & Investment Income | 2.66M | 1.04M | 3.39M | 3.08M | 1.04M | 66.00K |
| Other Non Operating Income (Expenses) | 5.35M | 6.72M | -1.05M | 2.54M | -1.96M | -1.35M |
| EBT Excluding Unusual Items | -109.87M | -95.47M | -95.71M | -93.61M | -87.44M | -75.69M |
| Impairment of Goodwill | -32.97M | |||||
| Asset Writedown | -4.80M | |||||
| Other Unusual Items | -1.70M | -1.70M | -17.25M | |||
| Pretax Income | -111.57M | -97.17M | -100.51M | -93.61M | -120.41M | -92.94M |
| Net Income | -111.57M | -97.17M | -100.51M | -93.61M | -120.41M | -92.94M |
| Net Income to Common | -111.57M | -97.17M | -100.51M | -93.61M | -120.41M | -92.94M |
| Shares Outstanding (Basic) | 27.91M | 15.57M | 10.02M | 4.43M | 3.18M | 2.37M |
| Shares Outstanding (Diluted) | 27.91M | 15.57M | 10.02M | 4.43M | 3.18M | 2.37M |
| EPS (Basic) | -4.00 | -6.24 | -10.03 | -21.12 | -37.84 | -39.30 |
| EPS (Diluted) | -4.00 | -6.24 | -10.03 | -21.12 | -37.84 | -39.30 |
| Free Cash Flow | -88.05M | -85.97M | -85.03M | -71.16M | -65.26M | -83.30M |
| Free Cash Flow Per Share | -3.15 | -5.52 | -8.49 | -16.06 | -20.51 | -35.22 |
| EBITDA | -117.73M | -103.06M | -97.92M | -99.11M | -86.44M | -74.33M |
| D&A For EBITDA | 149.00K | 168.00K | 134.00K | 111.00K | 77.00K | 85.00K |
| EBIT | -117.88M | -103.23M | -98.05M | -99.22M | -86.52M | -74.42M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 155.10M | 15.48M | 35.67M | 46.67M | 106.75M | 86.86M |
| Short-Term Investments | 9.63M | |||||
| Cash & Short-Term Investments | 155.10M | 15.48M | 35.67M | 46.67M | 116.37M | 86.86M |
| Other Receivables | 281.00K | 4.12M | 684.00K | 2.48M | 2.66M | 2.15M |
| Receivables | 281.00K | 4.12M | 684.00K | 2.48M | 2.66M | 2.15M |
| Prepaid Expenses | 2.45M | 2.06M | 1.87M | 2.31M | 5.61M | 15.97M |
| Other Current Assets | 1.20M | 1.11M | 1.07M | 1.23M | ||
| Total Current Assets | 157.83M | 22.87M | 39.33M | 52.53M | 125.86M | 104.99M |
| Property, Plant & Equipment | 1.34M | 1.18M | 1.54M | 1.76M | 1.85M | 1.10M |
| Goodwill | 32.97M | |||||
| Other Long-Term Assets | 43.00K | 42.00K | ||||
| Total Assets | 159.17M | 24.05M | 40.87M | 54.30M | 127.75M | 139.10M |
| Accounts Payable | 12.66M | 10.14M | 7.85M | 5.10M | 4.28M | 3.75M |
| Accrued Expenses | 17.85M | 18.64M | 12.91M | 18.66M | 7.99M | 7.07M |
| Current Portion of Leases | 239.00K | 470.00K | 740.00K | 695.00K | 571.00K | 408.00K |
| Other Current Liabilities | 504.00K | 1.36M | 676.00K | 271.00K | 239.00K | 177.00K |
| Total Current Liabilities | 31.26M | 30.62M | 22.18M | 24.73M | 13.08M | 11.40M |
| Long-Term Leases | 328.00K | 107.00K | 264.00K | 639.00K | 992.00K | 584.00K |
| Total Liabilities | 31.59M | 30.73M | 22.44M | 25.37M | 14.07M | 11.98M |
| Common Stock | 13.00K | 9.00K | 8.00K | 4.00K | 4.00K | 3.00K |
| Additional Paid-In Capital | 800.05M | 599.24M | 525.61M | 436.06M | 427.93M | 324.24M |
| Retained Earnings | -675.26M | -608.57M | -511.40M | -410.89M | -317.28M | -196.87M |
| Comprehensive Income & Other | 2.77M | 2.65M | 4.21M | 3.76M | 3.04M | -252.00K |
| Total Common Equity | 127.58M | -6.67M | 18.43M | 28.93M | 113.68M | 127.11M |
| Shareholders' Equity | 127.58M | -6.67M | 18.43M | 28.93M | 113.68M | 127.11M |
| Total Liabilities & Equity | 159.17M | 24.05M | 40.87M | 54.30M | 127.75M | 139.10M |
| Total Debt | 567.00K | 577.00K | 1.00M | 1.33M | 1.56M | 992.00K |
| Net Cash (Debt) | 154.53M | 14.91M | 34.66M | 45.34M | 114.81M | 85.87M |
| Net Cash Per Share | 5.54 | 0.96 | 3.46 | 10.23 | 36.08 | 36.30 |
| Filing Date Shares Outstanding | 13.64M | 13.05M | 9.02M | 8.99M | 4.44M | 2.79M |
| Total Common Shares Outstanding | 13.64M | 12.04M | 9.02M | 4.52M | 3.93M | 2.63M |
| Working Capital | 126.57M | -7.75M | 17.16M | 27.80M | 112.79M | 93.59M |
| Book Value Per Share | 9.35 | -0.55 | 2.04 | 6.40 | 28.92 | 48.27 |
| Tangible Book Value | 127.58M | -6.67M | 18.43M | 28.93M | 113.68M | 94.14M |
| Tangible Book Value Per Share | 9.35 | -0.55 | 2.04 | 6.40 | 28.92 | 35.75 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -111.57M | -97.17M | -100.51M | -93.61M | -120.41M | -92.94M |
| Depreciation & Amortization | 149.00K | 168.00K | 134.00K | 111.00K | 77.00K | 85.00K |
| Asset Writedown & Restructuring Costs | 4.80M | 32.97M | ||||
| Stock-Based Compensation | 16.17M | 8.86M | 8.53M | 7.10M | 7.93M | 5.95M |
| Other Operating Activities | 749.00K | 497.00K | 1.95M | 523.00K | 4.76M | 12.96M |
| Change in Accounts Payable | 4.99M | 1.24M | 3.15M | 817.00K | 799.00K | 176.00K |
| Change in Other Net Operating Assets | 1.78M | 601.00K | -2.81M | 14.23M | 8.73M | -9.46M |
| Operating Cash Flow | -87.72M | -85.81M | -84.77M | -70.83M | -65.14M | -83.23M |
| Capital Expenditures | -329.00K | -161.00K | -264.00K | -334.00K | -112.00K | -67.00K |
| Investment in Securities | 9.80M | -9.63M | ||||
| Investing Cash Flow | -329.00K | -161.00K | -264.00K | 9.46M | -9.74M | -67.00K |
| Long-Term Debt Issued | 74.27M | |||||
| Net Debt Issued (Repaid) | 74.27M | |||||
| Issuance of Common Stock | 188.82M | 65.58M | 274.00K | 1.03M | 99.77M | 45.84M |
| Other Financing Activities | -6.00K | -4.01M | -3.00M | |||
| Financing Cash Flow | 188.82M | 65.58M | 74.54M | 1.03M | 95.76M | 42.84M |
| Foreign Exchange Rate Adjustments | -982.00K | 205.00K | -517.00K | 262.00K | -993.00K | -130.00K |
| Net Cash Flow | 99.79M | -20.18M | -11.01M | -60.07M | 19.88M | -40.59M |
| Free Cash Flow | -88.05M | -85.97M | -85.03M | -71.16M | -65.26M | -83.30M |
| Free Cash Flow Per Share | -3.15 | -5.52 | -8.49 | -16.06 | -20.51 | -35.22 |
| Levered Free Cash Flow | -51.41M | -50.66M | -53.29M | -39.98M | -36.03M | -49.48M |
| Unlevered Free Cash Flow | -51.41M | -50.66M | -53.29M | -39.98M | -36.03M | -49.48M |
| Change in Working Capital | 6.78M | 1.84M | 330.00K | 15.05M | 9.53M | -9.28M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 99.88M | 64.20M | 90.08M | 67.72M | 62.10M | 251.21M |
| Enterprise Value | -54.65M | 29.86M | 31.91M | 9.48M | -9.52M | 141.87M |
| Last Close Price | 7.51 | 5.34 | 10.00 | 15.00 | 14.00 | 95.70 |
| PB Ratio | 0.80 | -9.62 | 4.89 | 2.34 | 0.55 | 1.98 |
| P/TBV Ratio | 0.80 | 4.89 | 2.34 | 0.55 | 2.67 | |
| Debt / Equity Ratio | 0.00 | -0.09 | 0.05 | 0.05 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -1.21 | 2.23 | -1.88 | -1.57 | -1.01 | -0.68 |
| Net Debt / EBITDA Ratio | 1.31 | 0.14 | 0.35 | 0.46 | 1.33 | 1.16 |
| Net Debt / FCF Ratio | 1.75 | 0.17 | 0.41 | 0.64 | 1.76 | 1.03 |
| Quick Ratio | 4.97 | 0.64 | 1.64 | 1.99 | 9.10 | 7.81 |
| Current Ratio | 5.05 | 0.75 | 1.77 | 2.12 | 9.62 | 9.21 |
| Return on Equity (ROE) | -138.17% | -1,653.15% | -424.44% | -131.28% | -100.01% | -65.02% |
| Return on Assets (ROA) | -66.80% | -198.76% | -128.79% | -68.13% | -40.53% | -30.30% |
| Return on Capital Employed (ROCE) | -92.20% | 1,572.20% | -524.50% | -335.60% | -75.40% | -58.30% |
| Earnings Yield | -54.62% | -151.37% | -111.58% | -138.24% | -193.89% | -37.00% |
| FCF Yield | -85.93% | -133.91% | -94.39% | -105.09% | -105.08% | -33.16% |
| Buyback Yield / Dilution | -156.51% | -55.42% | -126.03% | -39.29% | -34.52% | -51.00% |